In 2006, a report in the New England Journal of Medicine alleged that Tequin had been found to put users at an elevated risk for dysglycemia, a blood sugar metabolism disorder that may manifest as either hyperglycemia (high blood sugar) or hypoglycemia (low blood sugar). Initially, Bristol-Myers Squibb notified health care providers that product warnings would be enhanced. However, the company subsequently opted to terminate the manufacture of Tequin. The product is now available only as treatment for eye conditions, in the form of an eye drop.
If you experienced side effects after being prescribed Tequin, GetLegal has the tools and resources to help you find skilled legal representation to protect your rights. Visit our attorney directory, look for your geographic location and find the best lawyer for your situation.
A trust fund is a powerful tool that has stood the test of time. It is an essential instrument in modern wealth manageme... Read More
Arraignment is a pivotal moment within the criminal justice system, marking the formal initiation of criminal proceeding... Read More
The Constitution protects you from being searched without a valid reason. But what exactly constitutes a valid reason? A... Read More
How It Works